Alphabet, Starbucks drive Wall Street to record high
July 29, 2019
Pfizer to spinoff, merge off-patent drugs unit with Mylan
July 29, 2019

Pfizer in talks to transition EpiPen maker into generics spinoff: spokeswoman

Pfizer Inc is in talks to merge its contract manufacturer that produces Mylan’s EpiPen emergency allergy treatment into the new generics business it is creating by combining its older off-patent medicines unit with Mylan NV , a Pfizer spokeswoman said.

Powered by WPeMatico